The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Open accessAbstract
Objective: The serum of most neuromyelitis optica (NMO) patients contains autoantibodies (NMO‐IgGs) directed against the aquaporin‐4 (AQP4) water channel located on astrocyte foot processes in the perivessel and subpial areas of the brain. Our objectives were to determine the source of central nervous system (CNS) NMO‐IgGs and their role in disease pathogenesis. Methods: Fluorescence‐activated cell sorting and single‐cell reverse transcriptase polymerase chain reaction were used to identify overrepresented plasma cell immunoglobulin (Ig) sequences in the cerebrospinal fluid (CSF) of an NMO patient after a first clinical attack. Monoclonal recombinant antibodies (rAbs) were generated from the paired heavy and light chain sequences and tested for target specificity and Fc effector function. The effect of CSF rAbs on CNS immunopathology was investigated by delivering single rAbs to rats with experimental autoimmune encephalomyelitis (EAE). Results: Repertoire analysis revealed a dynamic, clonally expanded plasma cell population with features of an antigen‐targeted response. Using multiple independent assays, 6 of 11 rAbs generated from CSF plasma cell clones specifically bound to AQP4. AQP4‐specific rAbs recognized conformational epitopes and mediated both AQP4‐directed antibody‐dependent cellular cytotoxicity and complement‐mediated lysis. When administered to rats with EAE, an AQP4‐specific NMO CSF rAb induced NMO immunopathology: perivascular astrocyte depletion, myelinolysis, and complement and Ig deposition. Interpretation: Molecular characterization of the CSF plasma cell repertoire in an early NMO patient demonstrates that AQP4‐specfic Ig is synthesized intrathecally at disease onset and directly contributes to CNS pathology. AQP4 is now the first confirmed antigenic target in human demyelinating disease. Ann Neurol 2009;66:617–629
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239 · cited 5×
“The titration curves of the AQP4specific rAbs, serum, and CSF on the LN18AQP4 cell line were congruent (Fig 2C), indicating that the CSF plasma cell rAbs had similar binding affinity to serum and CSF NMO-IgG.”
BackgroundMethodInfluentialRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 494
The human immunoglobulin VH repertoire
Cook, G. P., & Tomlinson, I. M. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80166-9 · Cited by 436
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
Jarius, S., Aboul-Enein, F., Waters, P., Kuenz, B., Hauser, A., Berger, T., Lang, W., Reindl, M., Vincent, A., & Kristoferitsch, W. (2008) · Brain · doi:10.1093/brain/awn240 · Cited by 435
Reiber, H., & Lange, P. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.7.1153 · Cited by 417
Cepok, S., Rosche, B., Grummel, V., Vogel, F., Zhou, D., Sayn, J., Sommer, N., Hartung, H.-P., & Hemmer, B. (2005) · Brain · doi:10.1093/brain/awh486 · Cited by 367
Self-citationVincent, T., Saikali, P., Cayrol, R., Roth, A. D., Bar-Or, A., Prat, A., & Antel, J. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5730 · Cited by 243
Self-citationZhou, D., Srivastava, R., Nessler, S., Grummel, V., Sommer, N., Brück, W., Hartung, H.-P., Stadelmann, C., & Hemmer, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607242103 · Cited by 231
Self-citationOwens, G. P., Ritchie, A. M., Burgoon, M. P., Williamson, R. A., Corboy, J. R., & Gilden, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2725 · Cited by 209
Self-citationReceptor Editing Occurs Frequently during Normal B Cell Development
Retter, M. W., & Nemazee, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1231 · Cited by 198
Ritchie, A. M., Gilden, D. H., Williamson, R. A., Burgoon, M. P., Yu, X., Helm, K. M., Corboy, J. R., & Owens, G. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.649 · Cited by 78
Self-citationWinges, K. M., Gilden, D. H., Bennett, J. L., Yu, X., Ritchie, A. M., & Owens, G. P. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.009 · Cited by 52
Self-citationYu, X., Gilden, D., Ritchie, A. M., Burgoon, M. P., Keays, K. M., & Owens, G. P. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.010 · Cited by 39
Self-citationCSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome
Bennett, J. L., Haubold, K., Ritchie, A. M., et al. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.031 · Cited by 37
Self-citationBeyer, A.-M., Wandinger, K., Siebert, E., Zschenderlein, R., & Klehmet, J. (2007) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2007.08.018 · Cited by 12
Cited by
Jarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., Kleiter, I., Kleinschnitz, C., Berthele, A., Brettschneider, J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-14 · Cited by 764
Self-citationCree, B. A. C., Bennett, J. L., Kim, H. J., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., Fujihara, K., Paul, F., Cutter, G. R., Marignier, R., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31817-3 · Cited by 756
Self-citationAquaporin water channels in the nervous system
Papadopoulos, M. C., & Verkman, A. S. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3468 · Cited by 741
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Reindl, M., & Waters, P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0112-x · Cited by 626
Aquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 597
Metadata
- Authors
- Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., Gilden, D., Nessler, S., Stadelmann, C., & Hemmer, B.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2009-11
- Volume
- 66
- Issue
- 5
- Pages
- 617-629
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2077427574
- Cited by
- 590
- References
- 21
- FWCI
- 34.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.